Alkem Laboratories has announced the resignation of its Chief Executive Officer, Dr. Vikas Gupta. The resignation is effective from 30th June 2026, allowing for a smooth transition of responsibilities. Dr. Gupta is stepping down to pursue new professional opportunities.
The company disclosed this change in a regulatory filing under Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing included the necessary details as per the SEBI LODR Regulations and a copy of Dr. Gupta’s resignation letter.
Dr. Gupta has been a key managerial personnel at Alkem Laboratories, contributing significantly to the company’s operations. His departure marks a notable change in the leadership of the organisation.
Further information regarding this transition is available on the company’s official website.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).